Figure 5 — Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation

Research Paper|Volume 15, Issue 9|pp. 3839–3856

Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation

Back to articleFigure 5(5 of 8)

100%

Figure 5.GO and KEGG enrichment analysis. (A) The results of GO enrichment analysis (Top 10). (B) The results of KEGG pathway enrichment analysis (Top 30). (C) Schematic drawing of the MAPK signaling pathway.